Omega Fund Management, LLC Arcutis Biotherapeutics, Inc. Transaction History

Omega Fund Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$24.47 - $36.98 $400,402 - $605,103	-16,363 Reduced 2.56%	623,836 $18 Million
Q4 2020 Feb 16, 2021	SELL	$17.82 - $31.73 $333,394 - $593,636	-18,709 Reduced 2.84%	640,199 $18 Million
Q3 2020 Nov 16, 2020	SELL	$23.44 - $32.28 $4.35 Million - $6 Million	-185,772 Reduced 21.99%	658,908 $19.3 Million
Q1 2020 May 14, 2020	BUY	$18.5 - $36.9 $15.6 Million - $31.2 Million	844,680 New	844,680 $25.2 Million

218

129M

2.02M

202K

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $784M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

Get notified when there are updates to the investment portfolio of Omega Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Omega Fund Management, LLC with notifications on news.